Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma

Overview of attention for article published in Journal of Investigative Dermatology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,230 followers.

Congratulations to all authors! 👏👏👏 https://t.co/kePTDwhCvV #melanoma #medical #research

Repurposing melanoma chemotherapy to activate inflammasomes in treatment of BRAF/MAPK inhibitor resistant melanoma https://t.co/7dZNUYh8Y2 https://t.co/Cd9eK01s8i

New article: Repurposing melanoma chemotherapy to activate inflammasomes in treatment of BRAF/MAPK inhibitor resistant melanoma https://t.co/VHhuD6BHAD #melanoma #oncology https://t.co/9RLkUohomz

Delighted to share our latest findings- "Repurposing melanoma chemotherapy to activate inflammasomes in treatment of BRAF/MAPK inhibitor resistant melanoma" Excellent work from @Farzana&; @DrHYTseng. My #2 as a co-senior author. @CentenaryInst @Jess…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.